Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Appendiceal Neoplasms × DNA Fingerprinting × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1 Appendiceal Neoplasms 1 Adenocarcinoma, Mucinous 1

Interventions

Oxaliplatin 10 Mitomycin 9 Leucovorin 6 Hyperthermic Intraperitoneal Chemotherapy 6 Irinotecan 5 Fluorouracil 5 Capecitabine 4 Cytoreduction Surgical Procedures 3 Cisplatin 3 Trastuzumab 2 Thalidomide 2 Surveys and Questionnaires 2 Melphalan 2 Interleukin-12 Subunit p35 2 Floxuridine 2 Doxorubicin 2 Cetuximab 2 tipifarnib 1 surufatinib 1 sodium thiosulfate 1 sintilimab 1 nintedanib 1 nilotinib 1 motexafin lutetium 1 irinotecan sucrosofate 1 entinostat 1 durvalumab 1 dehydroftorafur 1 Yoga 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05734430 2025-04-18

GAP

Vanderbilt-Ingram Cancer Center

Gastrointestinal

Appendiceal Neoplasms, Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡